4//SEC Filing
ATAI Life Sciences AG 4
Accession 0000950170-24-052877
CIK 0001098880other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:05 PM ET
Size
8.2 KB
Accession
0000950170-24-052877
Insider Transaction Report
Form 4
ATAI Life Sciences B.V.
10% Owner
Transactions
- Other
Convertible Notes
2024-04-19(indirect: By ATAI Life Sciences AG)Exercise: $0.18From: 2024-04-19Exp: 2026-02-01→ Common Stock (5,405,405 underlying)
ATAI Life Sciences AG
10% Owner
Transactions
- Other
Convertible Notes
2024-04-19(indirect: By ATAI Life Sciences AG)Exercise: $0.18From: 2024-04-19Exp: 2026-02-01→ Common Stock (5,405,405 underlying)
Footnotes (2)
- [F1]On April 19, 2024, pursuant to the Third Amended and Restated Loan Agreement, ATAI AG provided to IntelGenX Corp. an additional term loan in an amount equal to $1,000,000, which is convertible to shares of Common Stock at a price of $0.185 per share. Any accrued interest outstanding under the loan may be converted into shares of Common Stock at the five day volume weighted average price of the shares, less the maximum permitted discount under certain applicable rules, ending on the day that is the second business day before the day the interest becomes due and payable.
- [F2]Reflects securities held of record by ATAI AG, which is a wholly owned subsidiary of ATAI Life Sciences N.V., and as a result, ATAI Life Sciences N.V. may be deemed to share beneficial ownership over the securities reported herein.
Documents
Issuer
IntelGenx Technologies Corp.
CIK 0001098880
Entity typeother
IncorporatedGermany
Related Parties
1- filerCIK 0001776242
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:05 PM ET
- Size
- 8.2 KB